Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Ambrish Mithal Group Chairman - Endocrinology & Diabetology, Max Super Speciality Hospital said, For someone who wants to lose weight, practitioners may still use the diabetes drug (generic), since higher-strength versions of the same drug are approved for it
Its no coincidence that Novo Nordisk (NVO) and Eli Lilly (LLY) are reporting earnings today
Given that both SGLT2i and GLP-1 RA demonstrate robust and consistent cardio-renal benefits [14], both agents seem to be an attractive option to fulfil an unmet therapeutic need in type 1 diabetes
It's not just about adding liquid
Trials seldom report outcomes before week 4, so early-week estimates are approximations
US$ 20.28
US$ 26.02
US$ 23.11
US$ 26.33
US$ 22.73
US$ 24.36
US$ 24.96
US$ 23.23
US$ 20.97
